253 related articles for article (PubMed ID: 28732103)
21. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
Rekhi B; Verma V; Gulia A; Jambhekar NA; Desai S; Juvekar SL; Bajpai J; Puri A
Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984
[TBL] [Abstract][Full Text] [Related]
22. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.
Girolami I; Mancini I; Simoni A; Baldi GG; Simi L; Campanacci D; Beltrami G; Scoccianti G; D'Arienzo A; Capanna R; Franchi A
J Clin Pathol; 2016 Mar; 69(3):240-7. PubMed ID: 26338802
[TBL] [Abstract][Full Text] [Related]
23. In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid.
Shibuya I; Takami M; Miyamoto A; Karakawa A; Dezawa A; Nakamura S; Kamijo R
Pathol Oncol Res; 2019 Jan; 25(1):409-419. PubMed ID: 29159783
[TBL] [Abstract][Full Text] [Related]
24. RANKL, denosumab, and giant cell tumor of bone.
Thomas DM
Curr Opin Oncol; 2012 Jul; 24(4):397-403. PubMed ID: 22581354
[TBL] [Abstract][Full Text] [Related]
25. Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone Pathology.
Treffel M; Lardenois E; Larousserie F; Karanian M; Gomez-Brouchet A; Bouvier C; Le Loarer F; Aubert S; de Pinieux G; Audard V; Rios M; Sirveaux F; Vignaud JM; Gauchotte G; Marie B
Am J Surg Pathol; 2020 Jan; 44(1):1-10. PubMed ID: 31651524
[TBL] [Abstract][Full Text] [Related]
26. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.
Park MJ; Ganjoo KN; Ladd AL
J Hand Surg Am; 2015 Aug; 40(8):1620-4. PubMed ID: 25935517
[TBL] [Abstract][Full Text] [Related]
27. Response of Aneurysmal Bone Cyst to Denosumab.
Skubitz KM; Peltola JC; Santos ER; Cheng EY
Spine (Phila Pa 1976); 2015 Nov; 40(22):E1201-4. PubMed ID: 26730528
[TBL] [Abstract][Full Text] [Related]
28. Denosumab treatment of giant cell tumour of bone.
Balke M
Lancet Oncol; 2013 Aug; 14(9):801-2. PubMed ID: 23867210
[No Abstract] [Full Text] [Related]
29. Denosumab: An Alternative Therapy for the Management of Giant Cell Lesions.
O'Connell JE; Kearns GJ
J Oral Maxillofac Surg; 2016 May; 74(5):873. PubMed ID: 26899479
[No Abstract] [Full Text] [Related]
30. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.
Ueda T; Morioka H; Nishida Y; Kakunaga S; Tsuchiya H; Matsumoto Y; Asami Y; Inoue T; Yoneda T
Ann Oncol; 2015 Oct; 26(10):2149-54. PubMed ID: 26205395
[TBL] [Abstract][Full Text] [Related]
31. Pseudosarcomatous Spindle Cell Proliferation With Osteoid Matrix Mimicking Osteosarcoma: A Distinct Histologic Phenotype in Giant Cell Tumor of Bone Following Denosumab Therapy.
Santosh N; Mayerson JL; Iwenofu OH
Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):e18-9. PubMed ID: 25789537
[No Abstract] [Full Text] [Related]
32. Current management of giant-cell tumor of bone in the denosumab era.
Nagano A; Urakawa H; Tanaka K; Ozaki T
Jpn J Clin Oncol; 2022 May; 52(5):411-416. PubMed ID: 35199172
[TBL] [Abstract][Full Text] [Related]
33. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
[TBL] [Abstract][Full Text] [Related]
34. A case of pelvic giant cell tumor of bone, complete remission with denosumab: long duration of response.
Bilgetekin I; Mammadkhanli O; Basal FB; Kandemir O; Canbay S; Oksuzoglu B
Anticancer Drugs; 2020 Jun; 31(5):533-535. PubMed ID: 31743134
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation.
Kerr DA; Brcic I; Diaz-Perez JA; Shih A; Wilky BA; Pretell-Mazzini J; Subhawong TK; Nielsen GP; Rosenberg AE
Am J Surg Pathol; 2021 Jan; 45(1):93-100. PubMed ID: 32773532
[TBL] [Abstract][Full Text] [Related]
36. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases.
Dubory A; Missenard G; Domont J; Court C
Spine (Phila Pa 1976); 2016 Jun; 41(11):E654-E660. PubMed ID: 27244112
[TBL] [Abstract][Full Text] [Related]
37. Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results.
Palmerini E; Ruggieri P; Angelini A; Boriani S; Campanacci D; Milano GM; Cesari M; Paioli A; Longhi A; Abate ME; Scoccianti G; Terzi S; Trovarelli G; Franchi A; Picci P; Ferrari S; Leopardi MP; Pierini M
Tumori; 2018 Oct; 104(5):344-351. PubMed ID: 30086700
[TBL] [Abstract][Full Text] [Related]
38. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
[TBL] [Abstract][Full Text] [Related]
39. Giant cell tumour of bone in the denosumab era.
van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
[TBL] [Abstract][Full Text] [Related]
40. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
Gong LH; Liu WF; Ding Y; Zhang W; Yang YK; Yu F; Wong GQ; Huang XY; Niu XH
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):449-454. PubMed ID: 29886590
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
